UNICA IRIS Institutional Research Information System

PISTIS, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 195.369
NA - Nord America 7.724
AS - Asia 3.137
SA - Sud America 540
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 10
Totale 206.848
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 193.341
US - Stati Uniti d'America 7.621
SG - Singapore 1.309
CN - Cina 1.279
SE - Svezia 583
UA - Ucraina 550
BR - Brasile 448
DE - Germania 246
GB - Regno Unito 207
VN - Vietnam 190
FI - Finlandia 151
FR - Francia 94
KR - Corea 81
CA - Canada 67
HK - Hong Kong 47
IN - India 45
AR - Argentina 42
NL - Olanda 37
PL - Polonia 31
AT - Austria 30
TR - Turchia 27
BD - Bangladesh 23
IQ - Iraq 22
MX - Messico 21
ES - Italia 19
ZA - Sudafrica 19
JP - Giappone 18
RU - Federazione Russa 18
MA - Marocco 15
BE - Belgio 13
IL - Israele 13
CZ - Repubblica Ceca 11
EC - Ecuador 11
EG - Egitto 11
EU - Europa 9
ID - Indonesia 9
UZ - Uzbekistan 9
VE - Venezuela 8
CL - Cile 7
CO - Colombia 7
PK - Pakistan 7
AU - Australia 6
AZ - Azerbaigian 6
IE - Irlanda 6
IR - Iran 6
LT - Lituania 6
PY - Paraguay 6
CH - Svizzera 5
CR - Costa Rica 5
PE - Perù 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
NP - Nepal 4
PH - Filippine 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
GR - Grecia 3
JM - Giamaica 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
CY - Cipro 2
EE - Estonia 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MY - Malesia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BW - Botswana 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KI - Kiribati 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
Totale 206.846
Salva come PNG Salva come JPEG
Città #
Cagliari 188.987
Uta 3.894
Fairfield 915
Ashburn 679
Woodbridge 641
Singapore 543
Chandler 435
Houston 416
Boardman 394
Dallas 385
Ann Arbor 383
Nyköping 339
Seattle 338
Wilmington 338
Cambridge 301
Jacksonville 267
Beijing 247
Dearborn 194
Los Angeles 142
Santa Clara 130
Shanghai 126
Hefei 115
New York 112
Nanjing 105
Boston 94
Seoul 79
Helsinki 68
Buffalo 63
Ho Chi Minh City 62
San Diego 52
Dong Ket 46
Hong Kong 46
Guangzhou 45
São Paulo 43
Milan 38
Munich 38
Nanchang 38
London 36
Hebei 32
Rome 31
Shenyang 31
Redwood City 29
Hanoi 28
Redondo Beach 28
Warsaw 27
The Dalles 26
Tianjin 26
Chicago 25
Frankfurt am Main 24
Mountain View 24
Jiaxing 22
Vienna 21
Nuremberg 20
Toronto 19
Jinan 18
Norwalk 18
Denver 17
Brooklyn 16
Kunming 16
San Francisco 16
Atlanta 15
Montreal 14
Brussels 13
Changsha 13
Phoenix 13
Tokyo 13
Verona 13
Washington 13
Auburn Hills 12
Augusta 12
Orange 12
Orem 12
Porto Alegre 12
San Mateo 12
Sèlegas 12
Amsterdam 10
Casablanca 10
Johannesburg 10
Rio de Janeiro 10
Sassari 10
Stockholm 10
Taizhou 10
Wuhan 10
Zhengzhou 10
Brasília 9
Leawood 9
Ningbo 9
Tashkent 9
Ankara 8
Baghdad 8
Cairo 8
Council Bluffs 8
Monmouth Junction 8
Poplar 8
Quartu Sant'elena 8
Victoria 8
Brno 7
Chennai 7
Düsseldorf 7
Lauterbourg 7
Totale 202.097
Salva come PNG Salva come JPEG
Nome #
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain 37.719
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 4.575
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 4.127
Maternal immune activation disrupts dopamine system in the offspring 4.086
Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis 3.437
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.340
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.332
Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems 3.049
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling 2.978
null 2.940
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.761
Endocannabinoid signaling in motivation, reward, and addiction: influences on mesocorticolimbic dopamine function 2.712
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.679
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.559
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas 2.505
null 2.498
Effects of maternal immune activation on dopamine activity in male and female offspring 2.416
PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors 2.413
null 2.394
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats 2.332
PPAR-alpha: a new target for the treatment of nocturnal frontal lobe epilepsy 2.323
Inhibitory inputs from rostromedial tegmental nucleus regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse 2.288
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.196
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives 2.156
Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: Involvement of the endocannabinoid system 2.125
Trattamenti farmacologici per la dipendenza da nicotina 2.012
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 1.997
Dynamic interactions between drugs of abuse and the endocannabinoid system: molecular mechanisms and functional outcome 1.985
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 1.946
The role of nuclear hormone receptors in cannabinoid function 1.919
Pharmacological treatments for nicotine dependence 1.882
Opposite responses to aversive stimuli in lateral habenula neurons 1.871
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. 1.826
Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-α nuclear receptors 1.815
Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice 1.807
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2 1.778
Cannabinoid withdrawal: where does the hypodopaminergic state come from? 1.775
Neurobiologia della dipendenza da nicotina 1.765
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.760
Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases 1.747
ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL 1.736
Characterization of wild-type (R100R) and mutated (Q100Q) GABA(A) alpha(6) subunit in Sardinian alcohol non-preferring rats (sNP) 1.730
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding 1.688
Neurobiology of nicotine addiction 1.636
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.627
Preclinical studies of cannabis addiction − relationships between the endocannabinoid and dopamine systems 1.585
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.581
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings 1.570
Environmental Tobacco Smoke During the Early Postnatal Period of Mice Interferes With Brain 18 F-FDG Uptake From Infancy to Early Adulthood – A Longitudinal Study 1.542
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features and emerging specificities of the two major endocannabinoids 1.541
The endocannabinoid system and nondrug rewarding behaviours 1.440
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons 1.427
Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus 1.396
Inhibition of anandamide hydrolysis differentially modulates cocaine-induced effects on rat mesolimbic system 1.392
Inhibition of anandamide hydrolysis antagonizes nicotine effects on neurons in the nucleus accumbens shell in the rat 1.351
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.334
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation 1.330
Peroxisome proliferator activated receptors type alpha modulate nicotine effects in the rat ventral tegmental area 1.325
Neurobiological mechanisms of cannabinoid addiction 1.265
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.233
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1-and non-CB1-mediated actions 1.138
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: Evidence for GABAB receptor-mediated effects 1.112
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons 1.097
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo 1.072
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 1.071
Endocannabinoids and the processing of value-related signals 1.058
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 1.040
Involvement of the endogenus cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: Electrophysiological evidence in vivo 1.023
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 989
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 946
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 901
Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction 897
Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology 853
null 850
null 841
Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate 822
null 800
Dietary Phospholipid-Bound Conjugated Linoleic Acid and Docosahexaenoic Acid Incorporation Into Fetal Liver and Brain Modulates Fatty Acid and N-Acylethanolamine Profiles 794
From surface to nuclear receptors: the endocannabinoid family extends its assets 773
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance 773
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal 762
null 747
Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors 745
Endocannabinoid signalling in midbrain dopamine neurons: more than physiology? 714
Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate (GHB) receptor in the rat brain 710
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation 701
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders 693
Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system 683
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. 678
Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition 674
Identification of metabolic biomarkers of chronic vagus nerve stimulation (VNS) in subjects with drug-resistant epilepsy (DRE) 672
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy 662
The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line 630
Braking Dopamine Systems: A New GABA Master Structure for Mesolimbic and Nigrostriatal Functions 613
Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study 589
Transgenerational Sex-dependent Disruption of Dopamine Function Induced by Maternal Immune Activation 545
Cognitive performance in aged rats is associated with differences in distinctive neuronal populations in the ventral tegmental area and altered synaptic plasticity in the hippocampus 533
Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice 517
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 508
Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity 493
Totale 195.273
Salva come PNG Salva come JPEG
Categoria #
all - tutte 258.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 258.668
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115.860 0 0 0 0 0 4.482 3.079 2.280 1.003 1.933 2.021 1.062
2021/202211.101 1.050 879 586 682 1.013 908 564 469 602 1.328 1.738 1.282
2022/202314.067 990 1.397 1.327 1.089 1.323 1.647 733 1.299 1.120 1.051 1.430 661
2023/202449.892 661 572 541 856 1.483 2.459 2.645 1.114 938 903 1.646 36.074
2024/202521.159 3.853 4.782 2.869 3.011 1.650 1.684 1.801 186 397 251 382 293
2025/20264.404 871 452 999 787 665 630 0 0 0 0 0 0
Totale 207.223